Emerging opportunities for the treatment of metabolic diseases: Glucagon-like peptide-1 based multi-agonists
26 It is also feasible that reduction in AMD risk factors such as obesity, cardiovascular disease, and hyperlipidemia with GLP-1RAs could further provide benefit by reducing systemic inflammation and vascular risk factors
Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet and behaviours, and executive chair and former CEO Saeju Jeong said the move into providing semaglutide is "in line with our mission to help everyone everywhere live better longer." The company is offering compounded semaglutide for $149 for the first month and $279 for subsequent months, pairing the supply of the drug to its digital health platform to create a system that can achieve "sustainable, long-term weight loss" and help people eventually taper off treatment whilst keeping the weight off, said Jeong in a LinkedIn post
Published research also discusses benefits related to collagen production, collagen synthesis, elastin production, and skin health in experimental settings
Who Might Benefit from Taking Ozempic or Another GLP1 Medication
